Lower drug prices won’t fix cancer care
commentary As breakthrough drugs offer critical hope to patients, lawmakers should focus on shoring up the social safety net Published May 15, 2026 10:05AM (EDT) Insurers frequently deny or delay cancer care to patients, including breakthrough immunotherapies like Keytruda (Shivansh Gupta/PA Images via Getty Images) After former President Jimmy CarterContinue Reading











